People who have been prescribed a weight-loss injection could be at a higher risk of developing an eye condition which can lead to blindness, a study has found.
Of the patients included within the study, 710 had type 2 diabetes, with 194 of those patients having been prescribed semaglutide. Over three years, 8.9% of these people on semaglutide had naion compared with 1.8% on the other drugs, the researchers found. Over three years, 6.7% of these people on semaglutide had naion compared with 0.8% who were taking other weight-loss drugs.
Graham McGeown, honorary professor of physiology at Queen’s University Belfast, said: “This research does suggest an association between semaglutide treatment and one form of sight-threatening optic neuropathy, but this would ideally be tested in larger studies.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: smh - 🏆 6. / 80 Read more »
Source: theage - 🏆 8. / 77 Read more »
Source: brisbanetimes - 🏆 13. / 67 Read more »
Source: GuardianAus - 🏆 1. / 98 Read more »
Source: GuardianAus - 🏆 1. / 98 Read more »